1. Home
  2. FUL vs VERA Comparison

FUL vs VERA Comparison

Compare FUL & VERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo H. B. Fuller Company

FUL

H. B. Fuller Company

HOLD

Current Price

$67.25

Market Cap

3.2B

Sector

Industrials

ML Signal

HOLD

Logo Vera Therapeutics Inc.

VERA

Vera Therapeutics Inc.

HOLD

Current Price

$42.26

Market Cap

3.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FUL
VERA
Founded
1887
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Home Furnishings
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.2B
3.4B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
FUL
VERA
Price
$67.25
$42.26
Analyst Decision
Buy
Strong Buy
Analyst Count
5
11
Target Price
$70.20
$76.60
AVG Volume (30 Days)
430.5K
1.0M
Earning Date
03-25-2026
02-25-2026
Dividend Yield
1.39%
N/A
EPS Growth
19.57
N/A
EPS
2.75
N/A
Revenue
$3,473,589,000.00
N/A
Revenue This Year
$2.31
N/A
Revenue Next Year
$2.76
N/A
P/E Ratio
$24.54
N/A
Revenue Growth
N/A
N/A
52 Week Low
$47.56
$18.53
52 Week High
$68.63
$56.05

Technical Indicators

Market Signals
Indicator
FUL
VERA
Relative Strength Index (RSI) 66.37 41.78
Support Level $64.94 $41.46
Resistance Level $68.63 $44.96
Average True Range (ATR) 1.78 2.22
MACD 0.52 -0.31
Stochastic Oscillator 88.57 19.07

Price Performance

Historical Comparison
FUL
VERA

About FUL H. B. Fuller Company

H.B. Fuller Co manufactures and sells adhesives, sealants, and other chemical-based products. The company organizes itself into three segments: Hygiene, Health and Consumable Adhesives, Engineering Adhesives, and Construction Adhesives. It generates the maximum revenue from hygiene, health, and consumable adhesives. This segment produces and supplies a full range of specialty industrial adhesives such as thermoplastic, thermoset, reactive, water-based, and solvent-based products for applications in various markets, including packaging, converting, nonwoven, and hygiene (disposable diapers, feminine care, and medical garments) and health and beauty. The company generates around half of its revenue in the United States.

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

Share on Social Networks: